Impact of antibiotic resistance on the development of recurrent and relapsing symptomatic urinary tract infection in kidney recipients

American Journal of Transplantation

Volumn 15, Issue 4, 2015, Pages 1021-1027

  Bodro, M ^a   Sanclemente, G ^a   Lipperheide, I ^a   Allali, M ^a   Marco, F ^a   Bosch, J ^a   Cofan, F ^a   Ricart, M J ^a   Esforzado, N ^a   Oppenheimer, F ^a   Moreno, A ^a   Cervera, C ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

antibiotic drug resistance; bacterial; clinical research practice; infection and infectious agents; infectious disease

Indexed keywords

AMIKACIN; CARBAPENEM DERIVATIVE; CEFAZOLIN; CIPROFLOXACIN; LINEZOLID; ANTIINFECTIVE AGENT;

ACUTE GRAFT REJECTION; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; CITROBACTER; DIABETES MELLITUS; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING KLEBSIELLA PNEUMONIAE; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RECURRENT DISEASE; RELAPSE; RISK FACTOR; SEX DIFFERENCE; URINARY TRACT INFECTION; MIDDLE AGED; PATHOPHYSIOLOGY; URINARY TRACT INFECTIONS;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MICROBIAL; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RECURRENCE; URINARY TRACT INFECTIONS;

EID: 84925341012     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.13075     Document Type: Article

References (38)

1. Giral M, Pascuariello G, Karam G, et al. Acute graft pyelonephritis and long-term kidney allograft outcome. Kidney Int 2002; 61: 1880-1886.
2. Pelle G, Vimont S, Levy PP, et al. Acute pyelonephritis represents a risk factor impairing long-term kidney graft function. Am J Transplant 2007; 7: 899-907.
3. Abbott KC, Swanson SJ, Richter ER, et al. Late urinary tract infection after renal transplantation in the United States. Am J Kidney Dis 2004; 44: 353-362.
4. Linares L, Garcia-Goez JF, Cervera C, et al. Early bacteremia after solid organ transplantation. Transplant Proc 2009; 41: 2262-2264.
5. Linares L, Cervera C, Cofan F, et al. Epidemiology and outcomes of multiple antibiotic-resistant bacterial infection in renal transplantation. Transplant Proc 2007; 39: 2222-2224.
6. Linares L, Cervera C, Cofan F, et al. Risk factors for infection with extended-spectrum and AmpC beta-lactamase-producing gram-negative rods in renal transplantation. Am J Transplant 2008; 8: 1000-1005.
7. Bodro M, Sabe N, Tubau F, et al. Risk factors and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in solid-organ transplant recipients. Transplantation 2013; 96: 843-849.
8. Livermore DM, Warner M, Hall LM, et al. Antibiotic resistance in bacteria from magpies (Pica pica) and rabbits (Oryctolagus cuniculus) from west Wales. Environ Microbiol 2001; 3: 658-661.
9. Reddy P, Zembower TR, Ison MG, Baker TA, Stosor V., Carbapenem-resistant Acinetobacter baumannii infections after organ transplantation. Transpl Infect Dis 2010; 12: 87-93.
10. Bergamasco MD, Barroso Barbosa M, de Oliveira Garcia D, et al. Infection with Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in solid organ transplantation. Transpl Infect Dis 2012; 14: 198-205.
11. de Gouvea EF, Martins IS, Halpern M, et al. The influence of carbapenem resistance on mortality in solid organ transplant recipients with Acinetobacter baumannii infection. BMC Infect Dis 2012; 12: 351.
12. Silva C, Afonso N, Macario F, Alves R, Mota A., Recurrent urinary tract infections in kidney transplant recipients. Transplant Proc 2013; 45: 1092-1095.
13. Lim JH, Cho JH, Lee JH, et al. Risk factors for recurrent urinary tract infection in kidney transplant recipients. Transplant Proc 2013; 45: 1584-1589.
14. Hooton TM, Bradley SF, Cardenas DD, et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis 2010; 50: 625-663.
15. Gupta K, Hooton TM, Naber KG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011; 52 (5): e103-e120.
16. Albert X, Huertas I, Pereiro II, Sanfelix J, Gosalbes V, Perrota C., Antibiotics for preventing recurrent urinary tract infection in non-pregnant women. Cochrane Database Syst Rev 2004; (3): CD001209.
17. Parasuraman R, Julian K., Urinary tract infections in solid organ transplantation. Am J Transplant 2013; 13: 327-36.
18. Nicolle LE, Bradley S, Colgan R, Rice JC, Schaeffer A, Hooton TM., Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis 2005; 40: 643-654.
19. Bellomo R, Kellum JA, Mehta R, Palevsky PM, Ronco C., Acute dialysis quality initiative II: The vicenza conference. Curr Opin Crit Care 2002; 8: 505-508.
20. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P., Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8: R204-R212.
21. Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012; 18: 268-281.
22. de la Torre-Cisneros J, Farinas MC, Caston JJ, et al. GESITRA-SEIMC/REIPI recommendations for the management of cytomegalovirus infection in solid-organ transplant patients. Enferm Infecc Microbiol Clin 2011; 29: 735-758.
23. Bodro M, Sabe N, Gomila A, et al. Risk factors, clinical characteristics, and outcomes of invasive fungal infections in solid organ transplant recipients. Transplant Proc 2012; 44: 2682-2685.
24. Lee K, Lim YS, Yong D, Yum JH, Chong Y., Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-beta-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp. J Clin microbiol 2003; 41: 4623-4629.
25. Bakir M, Bova JL, Newell KA, Millis JM, Buell JF, Arnow PM., Epidemiology and clinical consequences of vancomycin-resistant enterococci in liver transplant patients. Transplantation 2001; 72: 1032-1037.
26. Herati RS, Blumberg EA., Losing ground: Multidrug-resistant bacteria in solid-organ transplantation. Curr Opin Infect Dis 2012; 25: 445-449.
27. Garzoni C, Vergidis P., Methicillin-resistant, vancomycin-intermediate and vancomycin-resistant staphylococcus aureus infections in solid organ transplantation. Am J Transplant 2013; 13: 50-58.
28. Bert F, Larroque B, Paugam-Burtz C, et al. Microbial epidemiology and outcome of bloodstream infections in liver transplant recipients: an analysis of 259 episodes. Liver Transpl 2010; 16: 393-401.
29. van Delden C, Blumberg EA., Multidrug resistant gram-negative bacteria in solid organ transplant recipients. Am J Transplant 2009; 9 S27-S34.
30. Lee SO, Kang SH, Abdel-Massih RC, Brown RA, Razonable RR., Spectrum of early-onset and late-onset bacteremias after liver transplantation: Implications for management. Liver Transpl 2011; 17: 733-741.
31. Zhong L, Men TY, Li H, et al. Multidrug-resistant gram-negative bacterial infections after liver transplantation-spectrum and risk factors. J Infect 2012; 64: 299-310.
32. Barber AE, Norton JP, Spivak AM, Mulvey MA., Urinary tract infections: Current and emerging management strategies. Clin Infect Dis. 57: 719-724.
33. Rosen DA, Pinkner JS, Jones JM, Walker JN, Clegg S, Hultgren SJ., Utilization of an intracellular bacterial community pathway in Klebsiella pneumoniae urinary tract infection and the effects of FimK on type 1 pilus expression. Infect Immun 2008; 76: 3337-3345.
34. Sahly H, Navon-Venezia S, Roesler L, et al. Extended-spectrum beta-lactamase production is associated with an increase in cell invasion and expression of fimbrial adhesins in Klebsiella pneumoniae. Antimicrob Agents Chemother 2008; 52: 3029-3034.
35. Rodriguez-Bano J, Navarro MD, Romero L, et al. Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients. J Clin Microbiol 2004; 42: 1089-1094.
36. Itani KM, Wilson SE, Awad SS, Jensen EH, Finn TS, Abramson MA., Ertapenem versus cefotetan prophylaxis in elective colorectal surgery. N Engl J Med 2006; 355: 2640-2651.
37. Sexton DJ., Carbapenems for surgical prophylaxis ? N Engl J Med 2006; 355: 2693-2695.
38. Tacconelli E, Cataldo MA, Dancer SJ, et al. ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clin Microbiol Infect 2014; 20 Suppl 1: 1-55.